Company profile: Alpha Genesis
1.1 - Company Overview
Company description
- Provider of nonhuman primate biological products (serum, plasma, whole blood, PBMC, tissue samples), specific-pathogen-free primate models, and contract research services for biomedical research, including vaccine development, therapeutic drug therapies, and experimental surgical procedures. Offers AGI Diagnostics with health monitoring and ELISA/PCR/microbiology tests, environmental enrichment, and enriched housing facilities.
Products and services
- Nonhuman Primate Models: Supplies SPF-qualified nonhuman primate models for biomedical research, featuring specific-pathogen-free status for controlled experimental use in studies requiring pathogen exclusion
- Bio-Research Services: Delivers contract-based nonhuman primate research services for the scientific community, encompassing vaccine development, therapeutic drug therapies, and experimental surgical procedures
- AGI Diagnostics: Offers laboratory-grade diagnostic testing services for nonhuman primates, including health monitoring and laboratory tests like ELISA, PCR, and microbiology for colony assessment
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Alpha Genesis
Marvel Biotechnology
HQ: Canada
Website
- Description: Provider of biotech discovery and development of synthetic derivatives of proven drugs, including MB-204, a fluorinated derivative of istradefylline, for neurological diseases (depression, anxiety, Alzheimer's, ADHD), liver fibrosis due to NASH, and adjunctive cancer therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marvel Biotechnology company profile →
Syra Health
HQ: United States
Website
- Description: Provider of healthcare and managed-care solutions grounded in real-world evidence and insights, including a mental and behavioral health platform for assessments, education, symptom monitoring, and interventions; an EMR to streamline clinical workflows and manage patient health information; a real-time patient engagement bot; workforce staffing and MSPs; a population health insights hub; and education and training.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syra Health company profile →
Certis Oncology
HQ: United States
Website
- Description: Provider of precision oncology and translational science solutions, including Certis Oncology Intelligence® for predictive therapeutic response data from advanced cancer models with AI-driven bioinformatics; BarneyOI® cancer model database; CertisAI™ drug response prediction; O-PDX models; 3D cell cultures; and custom in vitro pharmacology and ex vivo assays, including cell line development, to help bridge the preclinical–clinical translation gap.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Certis Oncology company profile →
Cello Health
HQ: United States
Website
- Description: Provider of cutting-edge professional medical and marketing services to global pharmaceutical, biotechnology and health sectors, delivering a fusion of expertise through three distinct capabilities to unlock the potential of organisations, brands and assets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cello Health company profile →
Prime Global
HQ: United States
Website
- Description: Provider of medical communications services via a group of seven full-service medical communications agencies and two specialist consultancies, with a people-first focus on creative, innovative science communication.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prime Global company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Alpha Genesis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Alpha Genesis
2.2 - Growth funds investing in similar companies to Alpha Genesis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Alpha Genesis
4.2 - Public trading comparable groups for Alpha Genesis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →